Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
Aug. 20, 2026 07:00
Rigetti Computing Establishes Dedicated Systems Delivery Organization to Scale Customer Deployments and Advance Quantum Processor Roadmap
Aug. 20, 2026 07:00
Winshear Receives TSXV Approval to the Thunder Bay Gold Project Assessment Credit and Property Purchase
Aug. 20, 2026 06:15
Banijay Group: Special shares adjustments
Aug. 20, 2026 05:45
Virtuix Reports First Quarter Fiscal Year 2027 Results as Omni One Orders Increase 150% Following Meta Launch
Aug. 20, 2026 05:34
Ocean Power Technologies Provides Update to Previously Announced Preliminary Fiscal 2026 Financial Results
Aug. 20, 2026 05:33
Picard Medical Reports Second Quarter 2026 Financial Results
Aug. 20, 2026 05:30
Cadillac Mines Announces Significant High Grade Infill Drill Results at Kerr-Addison Open Pit, Including 2.13 Grams Per Tonne Gold Over 38.2 Metres Within the 2026 Mineral Resource Pit
Ultragenyx Announces U.S. FDA Approval of GENGLYCOS™ Gene Therapy, the First-Ever FDA-Approved Treatment Designed to Treat the Underlying Cause of Glycogen Storage Disease Type Ia (GSDIa)
